What type of study is this?

September 16, 2025European PsychiatryOpen Access

Home-based non-invasive brain stimulation for treatment-resistant depression

View Full Paper

Ask AI

Bookmark

Significant reduction in depressive symptoms was observed, with a 33.56% change in MADRS scores.
86.73% of the HB-tDCS sessions were completed, indicating high feasibility for home application.
The intervention involved 42 daily sessions with supervision to ensure safety and adherence to protocols.
Results support further exploration of HB-tDCS in treatment-resistant depression, though safety monitoring revealed some adverse effects.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational analysis shows reduced depressive symptoms in patients with treatment-resistant depression, indicating HB-tDCS may be a viable treatment option.

Cite This Study

Romero-Marín et al. (2025) studied this question.

synapsesocial.com/papers/68d454cb31b076d99fa5a33c https://doi.org/10.1192/j.eurpsy.2025.1699

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis shows reduced depressive symptoms in patients with treatment-resistant depression, indicating HB-tDCS may be a viable treatment option.

Home-based non-invasive brain stimulation for treatment-resistant depression

Key Points

Discussion

Implication

Cite This Study

Home-based non-invasive brain stimulation for treatment-resistant depression

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider